Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis

Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its exec...

Full description

Saved in:
Bibliographic Details
Published inRedox report : communications in free radical research Vol. 28; no. 1; p. 2152607
Main Authors Dong, Xing-Qiang, Chu, Li-Kai, Cao, Xu, Xiong, Qian-Wei, Mao, Yi-Ming, Chen, Ching-Hsien, Bi, Yun-Li, Liu, Jun, Yan, Xiang-Ming
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 31.12.2023
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.
AbstractList Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.
Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.
ABSTRACTRenal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.
Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.
Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and eventual chronic kidney diseases (CKD). The chemotherapeutic drug cisplatin elicits cytotoxicity causing renal tubular cell death, but its executing mechanisms of action are versatile and elusive. Here, we show that cisplatin induces renal tubular cell apoptosis and ferroptosis by disrupting glutathione (GSH) metabolism. Upon cisplatin treatment, GSH metabolism is impaired leading to GSH depletion as well as the execution of mitochondria-mediated apoptosis and lipid oxidation-related ferroptosis through activating IL6/JAK/STAT3 signaling. Inhibition of JAK/STAT3 signaling reversed cell apoptosis and ferroptosis in response to cisplatin induction. Using a cisplatin-induced acute kidney injury (CAKI) mouse model, we found that inhibition of JAK/STAT3 significantly mitigates cisplatin nephrotoxicity with a reduced level of serum BUN and creatinine as well as proximal tubular distortion. In addition, the GSH booster baicalein also reclaims cisplatin-induced renal tubular cell apoptosis and ferroptosis as well as the in vivo nephrotoxicity. In conclusion, cisplatin disrupts glutathione metabolism, leading to renal tubular cell apoptosis and ferroptosis. Rewiring glutathione metabolism represents a promising strategy for combating cisplatin nephrotoxicity.
Author Chu, Li-Kai
Cao, Xu
Bi, Yun-Li
Liu, Jun
Yan, Xiang-Ming
Dong, Xing-Qiang
Mao, Yi-Ming
Xiong, Qian-Wei
Chen, Ching-Hsien
Author_xml – sequence: 1
  givenname: Xing-Qiang
  surname: Dong
  fullname: Dong, Xing-Qiang
  organization: Children's Hospital of Soochow University
– sequence: 2
  givenname: Li-Kai
  surname: Chu
  fullname: Chu, Li-Kai
  organization: Children's Hospital of Soochow University
– sequence: 3
  givenname: Xu
  surname: Cao
  fullname: Cao, Xu
  organization: Children's Hospital of Soochow University
– sequence: 4
  givenname: Qian-Wei
  surname: Xiong
  fullname: Xiong, Qian-Wei
  organization: Children's Hospital of Soochow University
– sequence: 5
  givenname: Yi-Ming
  surname: Mao
  fullname: Mao, Yi-Ming
  organization: Shanghai Jiao Tong University School of Medicine
– sequence: 6
  givenname: Ching-Hsien
  surname: Chen
  fullname: Chen, Ching-Hsien
  organization: University of California Davis
– sequence: 7
  givenname: Yun-Li
  surname: Bi
  fullname: Bi, Yun-Li
  organization: Children's Hospital of Soochow University
– sequence: 8
  givenname: Jun
  orcidid: 0000-0002-0917-7449
  surname: Liu
  fullname: Liu, Jun
  email: junliu@suda.edu.cn, xm_yan0302@suda.edu.cn
  organization: Pediatric Institute of Soochow University, Children's Hospital of Soochow University
– sequence: 9
  givenname: Xiang-Ming
  surname: Yan
  fullname: Yan, Xiang-Ming
  organization: Children's Hospital of Soochow University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36692085$$D View this record in MEDLINE/PubMed
BookMark eNqFUstu1TAUjFARfcAngLJkk-JH4thCQqCqlEqV2MDaOvHj1pVjB9tp1b_Ht_e2oixg48fxzBzbM8fNQYjBNM1bjE4x4ugDpgNGCJFTgkgd8EAYGl80R3jsaUcE4Qd1XTHdFnTYHOd8U1eUCf6qOaSMCYL4cNTEC78WKNeuqrezKTBF7_LcJnPnkgubdkmxGFVyrQTwbVmn1ZtWGe9zCxtwIZdWubx4KC50LuhVGd3CEpcSs6uYoFtrUtrvXzcvLfhs3uznk-bn1_MfZ9-6q-8Xl2dfrjrFECodRRQNpleIM82FolYjTKklIChGdqSAGVF26KkGhizDE9WGDmKqDxaU95qeNJc7XR3hRi7JzZDuZQQnHwoxbSSk4pQ30vbUjIMSVI19z7nlqhcj4awHMmALtGp92mkt6zQbrUwoCfwz0ecnwV3LTbyVgo8CC1EF3u8FUvy1mlzk7PL2CyGYuGZJRibouHWwQt_92eupyaNjFTDsACrFnJOxTxCM5DYZ8jEZcpsMuU9G5X38i6dcNb76Xq_s_H_Zn3dsF2xMM9zF5LUscO9jsglCTYCk_5b4DROB0vk
CitedBy_id crossref_primary_10_2147_DDDT_S487496
crossref_primary_10_1016_j_lfs_2024_122720
crossref_primary_10_3389_fcimb_2024_1363276
crossref_primary_10_1080_0886022X_2024_2411359
crossref_primary_10_1007_s11255_024_04302_3
crossref_primary_10_2147_BCTT_S475860
crossref_primary_10_1186_s12958_024_01208_8
crossref_primary_10_3164_jcbn_23_127
crossref_primary_10_1007_s00604_023_06167_2
crossref_primary_10_1016_j_advms_2025_01_008
crossref_primary_10_1016_j_intimp_2024_113804
crossref_primary_10_1111_imr_13280
crossref_primary_10_1038_s41467_024_45706_0
crossref_primary_10_1016_j_cytogfr_2025_01_003
crossref_primary_10_1186_s40780_024_00330_4
crossref_primary_10_1016_j_biopha_2024_117689
crossref_primary_10_1016_j_jhazmat_2024_134371
crossref_primary_10_4103_jmau_jmau_86_24
crossref_primary_10_1007_s40620_024_01927_6
crossref_primary_10_3390_antiox12091728
crossref_primary_10_1016_j_freeradbiomed_2024_10_296
crossref_primary_10_3390_ijms25116239
crossref_primary_10_1021_acs_jproteome_4c00939
crossref_primary_10_3390_ijms24087608
crossref_primary_10_2147_JIR_S506964
crossref_primary_10_1016_j_xphs_2023_11_018
crossref_primary_10_3390_v15122373
crossref_primary_10_1186_s12935_025_03681_6
Cites_doi 10.1038/s41581-018-0052-0
10.1080/0886022X.2018.1532910
10.3390/ijms222413304
10.1016/j.kint.2017.06.030
10.1016/j.semnephrol.2020.01.002
10.1016/j.chembiol.2020.03.016
10.2147/JEP.S267383
10.3390/ijms17101681
10.1038/s41419-020-2256-z
10.1155/2014/967826
10.1681/ASN.2014030262
10.1038/s41418-022-01008-w
10.1083/jcb.202105043
10.1007/s40620-017-0392-z
10.1038/s41580-020-00324-8
10.1155/2020/2851349
10.1016/j.biocel.2012.08.016
10.1002/ptr.6507
10.1016/S0891-5849(99)00177-X
10.1146/annurev-med-050214-013407
10.1155/2020/7912763
10.1093/jn/134.3.489
10.1186/1477-5956-6-15
10.1038/aps.2010.186
10.1186/s12885-019-6233-9
10.3389/fphar.2019.00376
10.4143/crt.2016.572
10.1007/s00011-019-01258-4
10.1016/S0270-9295(03)00089-5
10.1038/s41419-022-04527-z
ContentType Journal Article
Copyright 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022
2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 The Author(s)
Copyright_xml – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022
– notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/13510002.2022.2152607
DatabaseName Taylor & Francis Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate REDOX REPORT
EISSN 1743-2928
ExternalDocumentID oai_doaj_org_article_f43e75c93c74488f8c4972864a251fa3
PMC9879199
36692085
10_1080_13510002_2022_2152607
2152607
Genre Research Article
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 82270713
  funderid: 10.13039/501100001809
– fundername: Gusu Health Talent Project of Suzhou
  grantid: GSWS2019017; GSWS2019052; GSW2020049
– fundername: Key Disease Project of Suzhou Health Commission
  grantid: LCZX201908
– fundername: Key Laboratory Foundation of Structural Deformities in Children of Suzhou
  grantid: SZS2022018
– fundername: Natural Science Foundation of Jiangsu Province of China
  grantid: BK20191176; SYS2019090
GroupedDBID ---
002
0YH
123
29P
36B
4.4
53G
ABDBF
ABFIM
ACUHS
ADCVX
AENEX
AIJEM
ALMA_UNASSIGNED_HOLDINGS
CS3
DGEBU
DU5
E01
EAP
EBD
EBS
EDH
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
H13
HCLVR
HZ~
M4Z
MV1
OK1
P2P
P76
P7B
RPM
SV3
TDBHL
TFL
TFT
TFW
TUS
AAYXX
CITATION
AAOAP
AAXYE
ABTAA
ACQMU
ADGTR
AFDYB
APNXG
AURDB
BFWEY
CGR
CUY
CVF
CWRZV
ECM
EIF
EJD
HGUVV
JEPSP
M46
NPM
OWHGL
PCLFJ
RIG
TTHFI
Z0Y
7X8
5PM
ID FETCH-LOGICAL-c600t-30305e4c086d89c3fd0133f2a9310f73a162cf543da60f61b3de359b3519384d3
IEDL.DBID 0YH
ISSN 1351-0002
1743-2928
IngestDate Wed Aug 27 01:32:03 EDT 2025
Thu Aug 21 18:38:34 EDT 2025
Thu Jul 10 23:46:42 EDT 2025
Thu Jan 02 22:54:50 EST 2025
Tue Jul 01 00:49:48 EDT 2025
Thu Apr 24 23:08:36 EDT 2025
Wed Dec 25 09:05:12 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords JAK/STAT3
ferroptosis
Acute kidney injury
Baicalein
apoptosis
Glutathione metabolism
Cisplatin
renal tubular
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-30305e4c086d89c3fd0133f2a9310f73a162cf543da60f61b3de359b3519384d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Co-first authors
ORCID 0000-0002-0917-7449
OpenAccessLink https://www.tandfonline.com/doi/abs/10.1080/13510002.2022.2152607
PMID 36692085
PQID 2769375260
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_f43e75c93c74488f8c4972864a251fa3
proquest_miscellaneous_2769375260
pubmed_primary_36692085
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9879199
crossref_citationtrail_10_1080_13510002_2022_2152607
informaworld_taylorfrancis_310_1080_13510002_2022_2152607
crossref_primary_10_1080_13510002_2022_2152607
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-12-31
PublicationDateYYYYMMDD 2023-12-31
PublicationDate_xml – month: 12
  year: 2023
  text: 2023-12-31
  day: 31
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Redox report : communications in free radical research
PublicationTitleAlternate Redox Rep
PublicationYear 2023
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_4_4_1
e_1_3_4_3_1
e_1_3_4_2_1
e_1_3_4_9_1
e_1_3_4_8_1
e_1_3_4_7_1
e_1_3_4_20_1
e_1_3_4_6_1
e_1_3_4_5_1
e_1_3_4_23_1
e_1_3_4_24_1
Ursini F (e_1_3_4_31_1); 2020
e_1_3_4_22_1
e_1_3_4_27_1
e_1_3_4_28_1
e_1_3_4_25_1
e_1_3_4_26_1
e_1_3_4_29_1
Doke T (e_1_3_4_21_1) 2022
e_1_3_4_30_1
e_1_3_4_12_1
e_1_3_4_13_1
e_1_3_4_34_1
e_1_3_4_10_1
e_1_3_4_33_1
e_1_3_4_11_1
e_1_3_4_32_1
e_1_3_4_16_1
e_1_3_4_14_1
e_1_3_4_15_1
Sreekumar PG (e_1_3_4_17_1) 2021; 10
e_1_3_4_18_1
e_1_3_4_19_1
References_xml – ident: e_1_3_4_2_1
  doi: 10.1038/s41581-018-0052-0
– ident: e_1_3_4_26_1
  doi: 10.1080/0886022X.2018.1532910
– ident: e_1_3_4_22_1
  doi: 10.3390/ijms222413304
– ident: e_1_3_4_27_1
  doi: 10.1016/j.kint.2017.06.030
– ident: e_1_3_4_30_1
  doi: 10.1016/j.semnephrol.2020.01.002
– ident: e_1_3_4_15_1
  doi: 10.1016/j.chembiol.2020.03.016
– ident: e_1_3_4_28_1
  doi: 10.2147/JEP.S267383
– ident: e_1_3_4_34_1
  doi: 10.3390/ijms17101681
– ident: e_1_3_4_12_1
  doi: 10.1038/s41419-020-2256-z
– ident: e_1_3_4_4_1
  doi: 10.1155/2014/967826
– ident: e_1_3_4_16_1
  doi: 10.1681/ASN.2014030262
– volume: 2020
  start-page: 175
  ident: e_1_3_4_31_1
  article-title: Lipid peroxidation and ferroptosis: the role of GSH and GPx4
  publication-title: Free Radic Biol Med
– ident: e_1_3_4_11_1
  doi: 10.1038/s41418-022-01008-w
– ident: e_1_3_4_10_1
  doi: 10.1083/jcb.202105043
– ident: e_1_3_4_14_1
  doi: 10.1007/s40620-017-0392-z
– ident: e_1_3_4_29_1
  doi: 10.1038/s41580-020-00324-8
– ident: e_1_3_4_8_1
  doi: 10.1155/2020/2851349
– ident: e_1_3_4_23_1
  doi: 10.1016/j.biocel.2012.08.016
– ident: e_1_3_4_9_1
  doi: 10.1002/ptr.6507
– ident: e_1_3_4_18_1
  doi: 10.1016/S0891-5849(99)00177-X
– ident: e_1_3_4_3_1
  doi: 10.1146/annurev-med-050214-013407
– ident: e_1_3_4_7_1
  doi: 10.1155/2020/7912763
– volume: 10
  issue: 5
  year: 2021
  ident: e_1_3_4_17_1
  article-title: Glutathione metabolism and the novel role of mitochondrial GSH in retinal degeneration
  publication-title: Antioxidants (Basel, Switzerland)
– ident: e_1_3_4_20_1
  doi: 10.1093/jn/134.3.489
– ident: e_1_3_4_19_1
  doi: 10.1186/1477-5956-6-15
– ident: e_1_3_4_24_1
  doi: 10.1038/aps.2010.186
– ident: e_1_3_4_5_1
  doi: 10.1186/s12885-019-6233-9
– ident: e_1_3_4_33_1
  doi: 10.3389/fphar.2019.00376
– ident: e_1_3_4_13_1
  doi: 10.4143/crt.2016.572
– ident: e_1_3_4_32_1
  doi: 10.1007/s00011-019-01258-4
– ident: e_1_3_4_6_1
  doi: 10.1016/S0270-9295(03)00089-5
– ident: e_1_3_4_25_1
  doi: 10.1038/s41419-022-04527-z
– start-page: S0962
  year: 2022
  ident: e_1_3_4_21_1
  article-title: The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development
  publication-title: Trends Cell Biol
SSID ssj0003698
Score 2.4929874
Snippet Renal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal dysfunction and...
ABSTRACTRenal proximal tubular cells are highly vulnerable to different types of assaults during filtration and reabsorption, leading to acute renal...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2152607
SubjectTerms Acute kidney injury
Acute Kidney Injury - chemically induced
Acute Kidney Injury - metabolism
Animals
Apoptosis
Baicalein
Cisplatin
Ferroptosis
Glutathione - metabolism
JAK/STAT3
Kidney - metabolism
Mice
renal tubular
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pa9swFBajh7HL2NL9yNYNDUZP9Rpbsiwdu7GuDDp2aKE3IcvSZkjsEDuM_Pd9T5azpAxy2cVgRQIp77Pfe_LT9xHy0YELzmxqEgXhb8JZphJZliaxKas8c8LJwLZ__UNc3fLvd_ndjtQX1oQN9MDDH3fuOXNFbhWzBWQS0kvLVZFJwQ14Zm8Czyf4vDGZiu9gJoIKLsrP4bnpbDy7I2fn2IZNkBtmcAH_JVBLdscrBfL-B9Sl_wpAH9ZR7jimy2fkaYwo6cWwkufkkWsm5PiigWx6saGnNNR4hs3zCXl8HT-lT8jpz4G0enNGb_6ewerOwogtnfXmmLTfAJxYo9g2ji5cD6iZ192CrtyfGjcFaaR66KAFJ9Kvy_XcUfwi0FHzy9QQgFJbd0usumuSuqkATRU1y3bZt10NfZqKerdaxfsX5Pby682XqyTKNCQWoqU-YfjOcNxCclRJZZmvIKxkPjMKQkdfMJOKzPqcs8qImRdpySrHclWiNCCTvGIvyVEDS3hNqORWoukcZIEcDF7aXElVlJiYijKdTQkfzaRt5DBHKY25TiPV6WhdjdbV0bpT8mk7bDmQeBwa8BkxsO2MHNyhAZCpIzL1IWROidpFkO7DFowf9FI0OzCBDyPcNDzvaDLTuHbd6QzFKwvsNCWvBvhtp8mEUKi5OiXFHjD31rH_S1P_DpziShYqVerN_1j4W_IE1sIGOswTctSv1u4dhG59-T48pffbnToh
  priority: 102
  providerName: Directory of Open Access Journals
Title Glutathione metabolism rewiring protects renal tubule cells against cisplatin-induced apoptosis and ferroptosis
URI https://www.tandfonline.com/doi/abs/10.1080/13510002.2022.2152607
https://www.ncbi.nlm.nih.gov/pubmed/36692085
https://www.proquest.com/docview/2769375260
https://pubmed.ncbi.nlm.nih.gov/PMC9879199
https://doaj.org/article/f43e75c93c74488f8c4972864a251fa3
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA9yB-KL6J4f9XSJIPd01W2Tps3jrrouwokPd6BPJU2Ts7DbLm0X2f_-ZtIPbw_lHnwptE3KlPlNMpNMfkPIOwNTcKgD5Utwf33OQuknWaZ8HbDcMiNM4tj2L76J1RX_-iMasgmbPq0SY2jbEUW4sRqNW2XNkBH3AYvKoSVDdBfCBWYggefJj0NEK0B69nM1DsZMuHK42AUPUIfDIZ5_feZgenIs_nc4TP_mid5NqLw1Qy2fkMe9a0nnHRaekgemnJCTeQlh9WZPz6hL9nSr6BPy8KLfU5-Qs-8de_X-nF7-OYzVnLseI6_1_oRUXwClmKxYlYZuTAvwWRfNhtbmd4Grg7TnfGjgCQrS7rLd2lDcGmioulYFeKJUF80W0-9KvyhzgFVO1bbatlVTQJsyp9bUdX__jFwtP19-XPl9vQZfg9vU-gwHD8M1REl5IjWzOfiXzIZKgg9pY6YCEWobcZYrMbMiyFhuWCQzrBHIEp6z5-SohF94SWjCdYKqMxAOch3zTEcykXGGEarIgplH-KCmVPdk5lhTY50GPefpoN0UtZv22vXI-7HbtmPzuK_DAjEwNkYybvegqq_T3rZTy5mJIy0ZCArjoU00l3GYCK7AebSKeUTeRlDaurUY2xVOSdk9Arwd4JaC4aPKVGmqXZOGWMUyxkYeedHBbxSTCSGx-KpH4gNgHvzH4Zuy-OXIxWUSy0DKV_8h8yl5BLeso8N8TY7aemfegOvWZlNnnFNyPF98WiynbgHkBiXwOfo
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfQkIAXBB0f5dNIaE8LNLHjxI8DMQqsEw-dNJ4sx7FHpDapmlSo_z13zgftBNoDL5GS2NFFd-e7s-9-R8hbCyY4MqEOJLi_AWeRDNIs04EJWe6YFTb1aPuzczG94F8v48udWhhMq8QY2rVAEX6tRuXGzeg-Je49dpVDVYbwLoILmCCBBeW3YzC-2L5h8mM6rMZM-H64OAUrqKO-iudfn9mzTx7G_xqI6d9c0esZlTsm6vQBud_5lvSkFYaH5JYtR-TwpIS4ermlR9Rne_pt9BG5M-sO1Ufk6HsLX709pvM_1Vj1sZ8xAFtvD0n1GcQUsxWr0tKlbUB-FkW9pGv7q8DtQdqBPtTwBAlpNtlmYSmeDdRUX-kCXFFqinqF-XdlUJQ5yFVO9apaNVVdwJgyp86u1939I3Jx-mn-cRp0DRsCA35TEzBcPSw3ECblqTTM5eBgMhdpCU6kS5gORWRczFmuxcSJMGO5ZbHMsEkgS3nOHpODEn7hKaEpNymyzkI8yE3CMxPLVCYZhqgiCydjwns2KdOhmWNTjYUKO9DTnrsKuas67o7Ju2HaqoXzuGnCB5SBYTCicfsH1fpKdcqtHGc2iY1kQCgsiC41XCZRKrgG79FpNiZyV4JU4zdjXNs5RbEbCHjTi5sCzUeW6dJWm1pF2MYywUFj8qQVv4FMJoTE7qtjkuwJ5t5_7L8pi58eXVymiQylfPYfNL8md6fz2Zk6-3L-7Tm5B69Yi435ghw06419CX5ck73yivob8fQ7Bw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9swDBaGDih2GbZ0j-ypAUNP9RZbsiwdu0eWPVr00ALbSZBlqTOQ2EHsYMi_HynbWVNs6GGXALalgAY_iqRMfSTktQMXnNjYRArC34izREUyz01kY1Z45oSTgW3_5FTMLviX7-lQTdj0ZZWYQ_uOKCKs1Wjcy8IPFXFvsakcWjJkdwn8gAcSeJ78dirB1wOkJz9m28WYidAOF6fgAepkOMTzr7_ZcU-Bxf8ah-nfItHrBZVXPNT0Hrnbh5b0uMPCfXLLVSNycFxBWr3Y0EMaij3DLvqI7J_039RH5PCsY6_eHNHzP4exmqMwY8trvTkg9SdAKRYr1pWjC9cCfOZls6Ar96vE3UHacz40cAcFadf5eu4ofhpoqLk0JUSi1JbNEsvvqqisCoBVQc2yXrZ1U8KYqqDerVb99QNyMf14_n4W9f0aIgthUxsxXDwct5AlFVJZ5guIL5lPjIIY0mfMxCKxPuWsMGLiRZyzwrFU5dgjkElesIdkr4JXeEyo5Fai6hykg9xmPLepkirLMUMVeTwZEz6oSduezBx7asx13HOeDtrVqF3da3dM3mynLTs2j5smvEMMbAcjGXe4Ua8udW_b2nPmstQqBoLCeuil5SpLpOAGgkdv2JioqwjSbdiL8V3jFM1uEODVADcNho8qM5Wr141OsItlhoPG5FEHv62YTAiFzVfHJNsB5s577D6pyp-BXFzJTMVKPfkPmV-S_bMPU_3t8-nXp-QOPGEdM-Yzsteu1u45RHFt_iLY6W_hWTo5
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glutathione+metabolism+rewiring+protects+renal+tubule+cells+against+cisplatin-induced+apoptosis+and+ferroptosis&rft.jtitle=Redox+report+%3A+communications+in+free+radical+research&rft.au=Dong%2C+Xing-Qiang&rft.au=Chu%2C+Li-Kai&rft.au=Cao%2C+Xu&rft.au=Xiong%2C+Qian-Wei&rft.date=2023-12-31&rft.issn=1351-0002&rft.eissn=1743-2928&rft.volume=28&rft.issue=1&rft_id=info:doi/10.1080%2F13510002.2022.2152607&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_13510002_2022_2152607
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-0002&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-0002&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-0002&client=summon